This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Anticoagulant Drugs Market & Antithrombotic Drugs Industry Analysis In New Research Reports

DALLAS, November 20, 2012 /PRNewswire/ --

- RnRMarketResearch.com adds new market research reports "Antithrombotic / Anticoagulant Drugs: Technologies and Global Markets" to its store.

This report provides an overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals. Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 as well as breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors are covered. The research also has a discussion of research and development of antithrombotic/anticoagulant treatments and comprehensive company profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs market for various cardiovascular applications.  The geographic scope of the report is global with a special emphasis on individual regions such as the United States, Europe, Japan and Rest of World.  The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Categories discussed in the report include:
  • Anticoagulants
  • Antiplatelets
  • Thrombin inhibitors

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2012 to 2017 and assessing the competitors and competitor market shares.

Buy your copy of this report @ http://www.rnrmarketresearch.com/antithrombotic-anticoagulant-drugs-technologies-global-markets-market-report.html.

This study is presented to increase the awareness of antithrombotic/ anticoagulant drugs to treat thrombotic disease and other diseases that are linked to thrombotic disease.  The study analyzes (1) select antithrombotic/anticoagulant drugs for treating various thrombotic diseases in coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; (2) the marketing of these drugs in the global market from different standpoints; and (3) the issues and trends affecting the market.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs